Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 16323421)

Published in Curr Top Microbiol Immunol on January 01, 2005

Authors

N Gironès1, H Cuervo, M Fresno

Author Affiliations

1: Centro de Biología Molecular, CSIC-UAM, Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.

Articles citing this

Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev (2011) 1.38

Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.11

DNA Vaccines against Protozoan Parasites: Advances and Challenges. J Biomed Biotechnol (2007) 0.95

Immune Evasion Strategies of Trypanosoma cruzi. J Immunol Res (2015) 0.95

Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev (2010) 0.92

Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection. PLoS One (2013) 0.92

Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection. J Cell Mol Med (2008) 0.87

Rethinking Molecular Mimicry in Rheumatic Heart Disease and Autoimmune Myocarditis: Laminin, Collagen IV, CAR, and B1AR as Initial Targets of Disease. Front Pediatr (2014) 0.85

Trypanosoma cruzi in the chicken model: Chagas-like heart disease in the absence of parasitism. PLoS Negl Trop Dis (2011) 0.85

A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging. J Biomol Screen (2014) 0.85

A population study of the minicircles in Trypanosoma cruzi: predicting guide RNAs in the absence of empirical RNA editing. BMC Genomics (2007) 0.84

Relevance of molecular mimicry in the mediation of infectious myocarditis. J Cardiovasc Transl Res (2013) 0.83

The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi. PLoS Pathog (2012) 0.82

Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine. Heart Fail Rev (2012) 0.82

Mucin AgC10 from Trypanosoma cruzi Interferes with L-selectin-mediated monocyte adhesion. Infect Immun (2010) 0.80

Chemotherapy of chronic indeterminate Chagas disease: a novel approach to treatment. Parasitol Res (2008) 0.76

New perspectives of infections in cardiovascular disease. Curr Cardiol Rev (2009) 0.76

Vaccination of dogs with Trypanosoma rangeli induces antibodies against Trypanosoma cruzi in a rural area of Córdoba, Argentina. Mem Inst Oswaldo Cruz (2016) 0.75

Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease. Pathog Immun (2016) 0.75

The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica (Cairo) (2013) 0.75

Unresolved issues in theories of autoimmune disease using myocarditis as a framework. J Theor Biol (2014) 0.75

Rheumatic diseases and the microbiome. Int J Rheum Dis (2014) 0.75

Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future. Acta Crystallogr F Struct Biol Commun (2015) 0.75

Evasion and Immuno-Endocrine Regulation in Parasite Infection: Two Sides of the Same Coin in Chagas Disease? Front Microbiol (2016) 0.75

Inhibition of autoimmune Chagas-like heart disease by bone marrow transplantation. PLoS Negl Trop Dis (2014) 0.75

Articles by these authors

(truncated to the top 100)

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med (2001) 2.22

Antigen-specific T lymphocyte clones. I. Characterization of a T lymphocyte clone expressing antigen-specific suppressive activity. J Exp Med (1981) 2.10

Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol (1992) 1.96

Use of cloned populations of mouse lymphocytes to analyze cellular differentiation. Cell (1981) 1.95

Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood (2000) 1.93

Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem (1977) 1.87

Antigen-specific T lymphocyte clones. II. Purification and biological characterization of an antigen-specific suppressive protein synthesized by cloned T cells. J Exp Med (1981) 1.86

Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer. Hum Pathol (1996) 1.81

Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett (1992) 1.65

The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol (1998) 1.53

An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem (2000) 1.52

Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol (1999) 1.36

Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. J Biol Chem (1998) 1.30

Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur J Immunol (1991) 1.22

Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem (1998) 1.21

Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha. J Biol Chem (2001) 1.19

A conformational epitope expressed upon association of CD3-epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies. J Immunol (1991) 1.16

Initiation of the polypeptide chain by reticulocyte cell-free systems. Survey of different inhibitors of translation. Eur J Biochem (1976) 1.15

The CD3-gamma and CD3-delta subunits of the T cell antigen receptor can be expressed within distinct functional TCR/CD3 complexes. EMBO J (1991) 1.12

Intra-Golgi transport inhibition by megalomicin. J Biol Chem (1996) 1.11

Antigen-specific T lymphocyte clones. III. Papain splits purified T suppressor molecules into two functional domains. J Exp Med (1982) 1.08

Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene (2006) 1.06

Hyperpathia and sensory level due to parietal lobe arteriovenous malformation. Arch Neurol (1981) 1.00

Narciclasine: an antitumour alkaloid which blocks peptide bond formation by eukaryotic ribosomes. FEBS Lett (1975) 0.99

Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J Immunol (1997) 0.99

Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J Clin Invest (2001) 0.98

An endoplasmic reticulum retention signal in the CD3 epsilon chain of the T-cell receptor. Nature (1992) 0.98

Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J Immunol (1994) 0.98

Transferrin receptor induces tyrosine phosphorylation in T cells and is physically associated with the TCR zeta-chain. J Immunol (1995) 0.97

Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J Biol Chem (2000) 0.97

Inhibitors of polypeptide elongation on yeast polysomes. J Antibiot (Tokyo) (1975) 0.97

Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells. J Biol Chem (2001) 0.95

Anaemia in advanced chronic fasciolosis. Acta Trop (2008) 0.93

Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha. Eur J Immunol (1995) 0.92

Bruceantin, a novel inhibitor of peptide bond formation. Biochim Biophys Acta (1978) 0.92

Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur J Immunol (2000) 0.91

Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT. J Virol (1998) 0.91

Proteins synthesized by inducer T cells: evidence for a mitogenic peptide shared by inducer molecules that stimulate different cell types. Cell (1982) 0.91

Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur J Immunol (1999) 0.90

IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. J Immunol (1997) 0.89

Activation by synergism between endotoxin and lymphokines of the mouse macrophage cell line J774 against infection by Trypanosoma cruzi. Parasite Immunol (1987) 0.89

Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation. J Allergy Clin Immunol (1997) 0.88

Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation. J Pharmacol Exp Ther (2001) 0.88

Encephalitozoon microsporidia modulates p53-mediated apoptosis in infected cells. Int J Parasitol (2006) 0.88

A tubulin-related 55 kilodalton surface antigen recognized by different Trypanosoma cruzi stage-specific monoclonal antibodies from infected mice. Mol Biochem Parasitol (1988) 0.88

Physical association and functional relationship between protein kinase C zeta and the actin cytoskeleton. Eur J Immunol (1995) 0.88

Characterization of a glycosyl-phosphatidylinositol-anchored membrane protein from Trypanosoma cruzi. Infect Immun (1991) 0.88

Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide. J Virol (2001) 0.87

Restriction of poliovirus RNA translation in a human monocytic cell line. Eur J Biochem (1989) 0.87

Expression of IkappaBalpha in the nucleus of human peripheral blood T lymphocytes. Oncogene (1999) 0.86

Allelic selection of human IL-2 gene. Eur J Immunol (2000) 0.86

Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells. J Immunol (1985) 0.86

Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation. AIDS (1996) 0.85

The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma. Vox Sang (2006) 0.85

Inhibitory effects of 'cap' analogues on globin mRNA and encephalomyocarditis RNA translation in a reticulocyte cell-free system. Eur J Biochem (1980) 0.85

A colorimetric assay based on cell viability for the indirect detection of intracellular replication and killing of Trypanosoma cruzi. J Immunol Methods (1987) 0.85

Involvement of nitric oxide on the cytokine induced growth of glial cell. Biochem Biophys Res Commun (1993) 0.85

Affinity-purified antigen-specific products produced by T cells share epitopes recognized by heterologous antisera raised against several different antigen-specific products from T cells. Cell Immunol (1983) 0.84

Sino-nasal adenocarcinoma: epidemiological and clinico-pathological study of 34 cases. J Otolaryngol (1993) 0.84

Mapping of genetic deletions on the long arm of chromosome 22 in human pancreatic adenocarcinomas. Anticancer Res (2001) 0.83

Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D. Vaccine (2003) 0.83

Laminin receptor in lymph node negative breast carcinoma. Cancer (1999) 0.83

Inhibition of interleukin 2-induced proliferation of cloned murine T cells by glucocorticoids. Possible involvement of an inhibitory protein. Eur J Immunol (1988) 0.82

EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity. Oncogene (2011) 0.82

Antiparasitic effects of the intra-Golgi transport inhibitor megalomicin. Antimicrob Agents Chemother (1998) 0.82

Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J Neurochem (2000) 0.82

Synergy of tumor necrosis factor with protein kinase C activators on T cell activation. Eur J Immunol (1990) 0.82

Megalomicin disrupts lysosomal functions. J Cell Sci (1997) 0.81

Alzheimer's amyloid precursor protein is expressed on the surface of hematopoietic cells upon activation. Biochim Biophys Acta (1996) 0.81

Regulation of interleukin-2 responses by phosphatidic acid. Eur J Immunol (1992) 0.81

Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site. J Immunol (1987) 0.81

GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression. Biol Res (1993) 0.81

Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells. J Gen Virol (1988) 0.80

Regulation of cyclooxygenase-2 expression in human mesangial cells--transcriptional inhibition by IL-13. Eur J Biochem (1999) 0.80

Trypanosoma cruzi tubulin eliminated in the urine of the infected host. J Parasitol (1998) 0.80

Induction of T cell activation by monoclonal antibodies specific for the transferrin receptor. Eur J Immunol (1990) 0.80

Role of soluble cytokines on the restricted replication of poliovirus in the monocytic U937 cell line. Virus Res (1990) 0.80

The role of protein kinase C in T lymphocyte proliferation. Existence of protein kinase C-dependent and -independent pathways. J Biol Chem (1988) 0.80

Tumor necrosis factor-alpha and nitric oxide in vertically HIV-1-infected children: implications for pathogenesis. Eur Cytokine Netw (2001) 0.79

Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. Clin Diagn Lab Immunol (2001) 0.79

A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies. J Exp Med (1992) 0.79

Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon. J Immunol (1983) 0.79

The detection of a spectrin-like protein in Trypanosoma cruzi with a polyclonal antibody. Cell Biol Int Rep (1988) 0.79

Activity of P536, a UDP-glucose analog, against Trypanosoma cruzi. Antimicrob Agents Chemother (1988) 0.78

Suppressor factor of T-cell activation and decreased interleukin 2 activity in experimental African trypanosomiasis. Infect Immun (1985) 0.78

HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. J Immunol (2001) 0.78

Physicochemical analysis of full-fat, reduced-fat, and low-fat artisan-style goat cheese. J Dairy Sci (2010) 0.78

Involvement of beta 1 integrins in the binding and entry of Trypanosoma cruzi into human macrophages. Eur J Immunol (1993) 0.78

Potentiation of interleukin-2 activity by levamisole and imidazole. Immunol Lett (1987) 0.78

Characterization of carbohydrate binding proteins in Trypanosoma cruzi. J Biol Chem (1995) 0.78

HIV-1 infection induces differentiation of immature neural cells through autocrine tumor necrosis factor and nitric oxide production. Virology (1999) 0.78

Biologic properties of a purified antigen-specific suppressive glycopeptide. Transplant Proc (1981) 0.78

Tumor necrosis factor-alpha (TNF-alpha), interferon-gamma, and interleukin-6 but not TNF-beta induce differentiation of neuroblastoma cells: the role of nitric oxide. J Neurochem (1994) 0.78

Massive glycation of protein HC, a low molecular weight lipocalin, in non-diabetic individuals. FEBS Lett (1997) 0.77

Cell type determines the relative proportions of (-) and (+) strand RNA during poliovirus replication. Virus Res (1991) 0.77

Different functional domains on the transferrin receptor molecule defined by monoclonal antibodies. Immunology (1989) 0.77

Early and late heat-induced proteins during Leishmania mexicana transformation. Biochem Biophys Res Commun (1988) 0.77

Initiation of protein synthesis in eukaryotic systems with native 40 S ribosomal subunits: effects of translation inhibitors. Methods Enzymol (1979) 0.77

Binding specificity of mannose-specific carbohydrate-binding protein from the cell surface of Trypanosoma cruzi. Glycobiology (2001) 0.77

Initiation of translation with native 40-S ribosomal subunits. Eur J Biochem (1978) 0.77